Sage Mountain Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MCMC
Sage Mountain Advisors's ARKG Position: Q1 2022 in Review
Sage Mountain Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 150 shares — an estimated $9K sold.
Sage Mountain Advisors first reported a position in ARKG in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.
- Sage Mountain Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
- Sage Mountain Advisors sold 150 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $9K.
- Sage Mountain Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 1 quarter.
- Sage Mountain Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q4 2021.
- 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.
Based on Sage Mountain Advisors's 13F filing for Q1 2022, filed 10 May 2022.